*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
The efficacy of combined management of endometriosis-associated infertility

Author: ORAZOV M.R, RADZINSKY V.Y., KHAMOSHINA M.B, KOSTIN I.N, TOKTAR L.R, KAVTELADZE E.V, SHUSTOVA V.B, ?HITANAVA Y.S, MINAEVA A.V
Abstract: Objective:To evaluate the effectiveness of combined therapy of endometriosis-associated infertility. Materials and Methods: 69 (n = 69) patients with infertility and verified diagnosis of genital endometriosis, were included in the study. In dependence of the medication, patients were divided into two groups. I group included patients (n = 34) only with surgical treatment, group II (n = 35) – patients with combined therapy (surgical treatment + hormone therapy). After surgery patients from II group received dydrogesterone 10 mg per day from the 14th to the 25th day of the menstrual cycle, for 6 months, according to the instruction. The effectiveness of treatment was assessed by the frequency of clinical pregnancy within a year. Results: The analysis revealed statistically significant differences in the pregnancy rate. So, with the use of surgical treatment, the pregnancy rate within 6 months reached 23.5%, which is consistent with the literature, while using the combined treatment, the pregnancy rate for 6 months was 37.1% (p = 0.2195), but there were no statistically significant differences. However, after a year of follow-up in women with the combined therapy applied, the pregnancy rate was 1.5 times higher, compared to only surgical approach (N=26–76.5% versus N=15–44.1% p = 0.004 (p<0.005). However, the 12-month pregnancy rate was 1.5 times higher in the group with the complex management compared to mono-surgical treatment. Conclusions: In our opinion, considering all the pathogenetic peculiarities of endometriosis, patients with endometriosis-associated infertility require hormonal support during the second phase of the menstrual cycle, which allows to overcome the possible insufficiency of early implantation and increasing the incidence of pregnancy and improving the prediction of perinatal outcomes.
Keyword: endometriosis, infertility, surgery treatment, hormonal therapy, bleeding,postpartum hemorrhage, pregnancy,massivebleeding,obstetricbleeding,hypotoniaofthe uterus,Cesareansection,rehabilitations
DOI: https://doi.org/10.31838/ijpr/2019.11.03.100
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free